Hisamitsu Pharmaceutical Co. Inc (HPX F) stock market data APIs
€22.1751
0(0%)
as of November 7, 2025
Try our APIs with
free plan!
Hisamitsu Pharmaceutical Co. Inc Financial Data Overview
Price chart is built with
Anychart
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company offers OTC products, such as, external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete's foot; and ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders. It also exports its products to Asia, the United States, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.
Prev. Close
22.1751
Open
22.1751
High
22.1751
Low
22.1751
52 wk Range
21.4-28.2348
Market Cap
1 547 M
P/E Ratio
14.4737
Shares Outstanding
70 341 K
Revenue
155 493 M
Dividends (Yield)
0.0245
Beta
0.401
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Hisamitsu Pharmaceutical Co. Inc data using free add-ons & libraries
Get Hisamitsu Pharmaceutical Co. Inc Fundamental Data
Hisamitsu Pharmaceutical Co. Inc Fundamental data includes:
- Net Revenue: 155 493 M
- EBITDA: 24 861 M
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-09
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Hisamitsu Pharmaceutical Co. Inc News
New
Does Hisamitsu Pharmaceutical Offer a Compelling Opportunity After Its Recent Share Price Rebound?
Thinking about what’s next for your Hisamitsu Pharmaceutical shares? You’re not alone. Investors have been watching the stock with a curious mix of optimism and caution, especially after seeing it...
LVMH: Share transactions disclosure
LVMH Paris, September 9th, 2025 The disclosure of share transactions carried out from September 1st to September 5th, 2025, was sent to the AMF on September 9th, 2025. As required by current law, th...
French Industrial Output Retreated in July
Production was down 1.1% on month, with output falling in transport manufacturing, electrical equipment and pharmaceuticals. Continue Reading View comments
Thales and HII partners to develop advanced autonomous undersea mine countermeasure capabilities
HII LONDON, Sept. 09, 2025 (GLOBE NEWSWIRE) -- HII (NYSE: HII) and Thales today announced the successful integration and field exercise of the Thales SAMDIS1 600 sonar with HII’s next generation RE...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
